Lucid Diagnostics IncLUCD
Price$0.63

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.4M+81.2% YoYTTM through 30 Sep 2025
Net Income -$52.3MTTM through 30 Jun 2026
Free Cash Flow -$47.2MTTM through 30 Jun 2026

Margins

Current
Operating Margin-963.4%
Net Margin-1,188.0%

Returns

-297.5%ROE
-100.5%ROA

Balance Sheet Health

Debt / Equity6.30x
Current Ratio1.07x
Net Debt-$2.7Mnet cash position
Cash & Equivalents$47.3M

Quality Metrics

Altman Z-Score-11.49
Piotroski F-Score3 / 9
FCF Margin-1,072.6%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'24'25
FY2025: $4.7M
Diluted EPS-$0.77TTM
'21'22'23'24'25
FY2025: $-0.57

Dividend

No dividend

Capital Allocation

Capex Intensity7.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.